Home Tags Anti-Nectin-4

Tag: anti-Nectin-4

AACR 2023: Preclinical Data Highlights Stable and Efficacious Low Drug-Load ADCs

Two poster presentations at the American Association for Cancer Research (AACR) 2023 Annual Meeting, being held April 14-19, 2023 at the Orange County Convention Center in Orlando, Florida, highlight late-breaking preclinical data from studies with an anti-Nectin-4 ADC and anti-HER2 ADC.

Breakthrough Therapy Designation Granted for Enfortumab Vedotin in Locally Advanced or...

This week the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to enfortumab vedotin, an antibody-drug conjugate or ADC, for patients with...